Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1 USD | -1.53% | 0.00% | -0.10% |
Chart calendar Emmaus Life Sciences, Inc.
Upcoming events on Emmaus Life Sciences, Inc.
Past events on Emmaus Life Sciences, Inc.
2023-11-14 09:30 | Q3 2023 Earnings Release |
2023-08-14 15:54 | Q2 2023 Earnings Release |
2023-05-15 09:30 | Q1 2023 Earnings Release |
2023-03-31 16:15 | Q4 2022 Earnings Release |
2022-12-08 17:00 | Annual General Meeting |
2022-11-14 18:17 | Q3 2022 Earnings Release |
2022-08-15 16:30 | Interim 2022 Earnings Release |
2022-06-23 12:30 | OTC Markets Group Zacks Virtual Life Sciences Investor Conference |
2022-05-24 07:00 | H.C. Wainwright Global Life Sciences Investment Conference |
2022-05-13 08:23 | Q1 2022 Earnings Release |
2022-05-03 15:30 | Interim Investor Summit |
2022-04-02 | Meeting of the British Society for Haematology - E-Poster No.: BSH22- EP78 |
2022-03-31 17:24 | FY 2021 Earnings Release |
2022-01-10 07:00 | H.C. Wainwright BioConnect Conference |
2021-12-16 12:30 | OTC Markets Life Sciences Investor Forum |
2021-12-13 18:00 | American Society of Hematology Virtual Meeting and Exposition |
2021-11-22 | Annual General Meeting |
2021-11-16 14:00 | Investor Meeting |
2021-11-12 08:23 | Q3 2021 Earnings Release |
2021-01-25 12:13 | FY 2020 Earnings Release |
Annual results
Fiscal Period | December | 2020 | 2021 | 2022 |
---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 20,6 23,0 -10.39% | 18,4 18,6 -1.18% |
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
EBIT Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -6,59 -5,40 -21.94% |
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - |
Net income Million USD | Released Forecast Spread | 1,10 | 0,00 0,00 - | 0,00 0,00 - |
EPS USD | Released Forecast Spread | 0,02 | 0,00 0,00 - | 0,00 0,00 - |
Announcement Date | 04/05/21 | 31/03/22 | 31/03/23 |
Quarterly results
Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3,02 6,63 -54.46% | 3,23 6,00 -46.1% | 4,29 6,00 -28.55% | 4,94 6,00 -17.68% | 5,93 7,00 -15.29% | 6,75 5,00 35.06% |
EBIT Million USD | Released Forecast Spread | -4,97 2,25 -320.96% | |||||
Announcement Date | 31/03/22 | 13/05/22 | 15/08/22 | 14/11/22 | 31/03/23 | 15/05/23 |
Past sector events for Emmaus Life Sciences, Inc.
2024-05-02 16:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 16:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
2024-05-02 16:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 16:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
2024-05-02 08:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
2024-05-02 07:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-02 07:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
2024-05-02 06:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
- Stock Market
- Equities
- EMMA Stock
- Calendar Emmaus Life Sciences, Inc.